FMC-NA Names Joe Turk New President for Renal Therapies Group
Joseph (Joe) Turk succeeds Mark Constanzo, who recently retired, as the new President for the Fresenius Medical Care North America Renal Therapies Group, and will now oversee the renal products and pharmaceutical operations.
Read the full article » | Posted 08-12-2021
Related Articles
- Fresenius Medical Care named Shervin Korangy as CEO Posted 10-22-2026
- Aligning Clinical Excellence with Health System Goals Through PD in Value-Based Models Posted 10-22-2026
- Update on National Institutes of Health websites Posted 10-22-2026
- What to Know About the American Society of Nephrology Kidney Week Posted 10-22-2026